Back

Cytopenias and Functional Defects in a Novel Murine Model of VPS45 Severe Congenital Neutropenia

Newburger, P. E.; Soares de Brito, J.; Zhu, Z.; Norris, K.; Buwa, N.; Furgason, M.; Opari-Nadi, P.; Woda, B.; Klein, C.; Munson, M.

2026-06-19 immunology
10.64898/2026.06.15.732420 bioRxiv
Show abstract

Mutations in the VPS45 gene are associated with a rare form of severe congenital neutropenia (SCN5), a life-threatening inherited error of immunity. We developed and characterized a novel mouse model of SCN5 by CRISPR/Cas9-mediated knock-in of pathogenic VPS45 E238K and T224N mutations. Both Vps45 mutations led to decreased protein expression in bone marrow cells. In vivo phenotyping demonstrated a non-Mendelian genetic distribution with reduced numbers of knock-in homozygotes Vps45E238K. Vps45E238K knock-in homozygous mice showed reduced body weight, reduced body condition with age, and increased mortality. As in human SCN5, Vps45E238K knock-in homozygotes demonstrated neutropenia and lymphopenia. Functionally, Vps45E238K knock-in homozygote neutrophils exhibited increased lipopolysaccharide-induced apoptosis and decreased peroxide production, phagocytic capacity and in vivo cell migration, phenocopying the functional defects reported in patients. Vps45T224N knock-in homozygous mice showed a milder phenotype or no abnormalities. In conclusion, this mouse model phenocopies, in part, human SCN5. It provides a novel platform for future studies of the pathophysiology of defects in neutrophil number and function in human SCN5, potential therapies for the disease, and the biochemistry and cell biology of VPS45. Summary statementWe report a mouse model of severe congenital neutropenia due to VPS45 missense mutations. It represents the first animal model of human neutropenia due to a defect in intracellular trafficking.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
Disease Models & Mechanisms
20 papers in training set
Top 0.1%
36.4%
2
Frontiers in Immunology
638 papers in training set
Top 0.7%
13.7%
50% of probability mass above
3
PLOS ONE
5266 papers in training set
Top 23%
7.1%
4
Scientific Reports
3612 papers in training set
Top 24%
4.3%
5
The Journal of Immunology
166 papers in training set
Top 0.9%
3.4%
6
Journal of Leukocyte Biology
42 papers in training set
Top 0.2%
2.8%
7
Orphanet Journal of Rare Diseases
21 papers in training set
Top 0.4%
1.2%
8
Discovery Immunology
11 papers in training set
Top 0.1%
1.2%
9
PLOS Pathogens
820 papers in training set
Top 7%
1.2%
10
Nature Communications
5641 papers in training set
Top 51%
1.1%
11
eLife
5828 papers in training set
Top 59%
1.1%
12
JCI Insight
277 papers in training set
Top 6%
1.1%
13
Journal of Clinical Immunology
14 papers in training set
Top 0.1%
1.0%
14
Journal of Clinical Investigation
179 papers in training set
Top 5%
0.9%
15
Cell Death & Disease
21 papers in training set
Top 0.5%
0.6%
16
Frontiers in Genetics
230 papers in training set
Top 6%
0.6%
17
Disease Models & Mechanisms
119 papers in training set
Top 3%
0.6%
18
Muscle & Nerve
10 papers in training set
Top 0.4%
0.6%
19
The Journal of Infectious Diseases
202 papers in training set
Top 5%
0.5%
20
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 46%
0.5%
21
Blood
74 papers in training set
Top 1%
0.5%
22
Frontiers in Pediatrics
32 papers in training set
Top 1%
0.5%
23
Human Mutation
34 papers in training set
Top 0.6%
0.5%
24
Blood Advances
62 papers in training set
Top 1%
0.5%
25
mBio
833 papers in training set
Top 13%
0.5%